Issues around medicine stock keeping, storage and electronic recording were revealed during an audit conducted by the Directorate General of Health Services and WHO
Illegal alprazolam manufacturing unit run by technically skilled operators highlights growing misuse of restricted psychotropic drugs under the NDPS Act.